Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma

Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAC) has a poor prognosis. One treatment approach, investigated here, is to reinforce antitumor immunity. Dendritic cells (DCs) are essential for the development and regulation of adaptive host immune responses against tumors. A major role for DCs may be as innate tumorici...

Full description

Bibliographic Details
Main Authors: Aurélie Collignon, Françoise Silvy, Stéphane Robert, Malika Trad, Sébastien Germain, Jérémy Nigri, Frédéric André, Véronique Rigot, Richard Tomasini, Bernard Bonnotte, Dominique Lombardo, Eric Mas, Evelyne Beraud
Format: Article
Language:English
Published: Taylor & Francis Group 2018-12-01
Series:OncoImmunology
Subjects:
active immunotherapy
animal models
cancer vaccines
folfirinox
dc-based tumor immunotherapy
pancreatic cancer
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1504727

Internet

http://dx.doi.org/10.1080/2162402X.2018.1504727

Similar Items